Makuuchi M. Hasegawa H. Yamazaki S.

Ultrasonically guided subsegmentectomy.

Surg Gynecol Obstet. 1985; 161: 346-350Rifkin M.D. Rosato F.E. Branch H.M. et al.

Intraoperative ultrasound of the liver. An important adjunctive tool for decision making in the operating room.

Ann Surg. 1987; 205: 466-472Durot I. Wilson S.R. Willmann J.K.

Contrast-enhanced ultrasound of malignant liver lesions.

Abdom Radiol (NY). 2018; 43: 819-847Malone C.D. Fetzer D.T. Monsky W.L. et al.

Contrast-enhanced US for the interventional radiologist: current and emerging applications.

Radiographics. 2020; 40: 562-588Torzilli G. Del Fabbro D. Olivari N. et al.

Contrast-enhanced ultrasonography during liver surgery.

Br J Surg. 2004; 91: 1165-1167Ranganath P.G. Robbin M.L. Back S.J. et al.

Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology.

Abdom Radiol (NY). 2018; 43: 998-1012

How to develop a contrast-enhanced ultrasound program.

J Ultrasound Med. 2017; 36: 1225-1240Maruyama H. Sekimoto T. Yokosuka O.

Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.

J Gastroenterol. 2016; 51: 421-433Yanagisawa K. Moriyasu F. Miyahara T. et al.

Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

Ultrasound Med Biol. 2007; 33: 318-325Claudon M. Dietrich C.F. Choi B.I. et al.

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Ultraschall Med. 2013; 34: 11-29Dietrich C.F. Averkiou M. Nielsen M.B. et al.

How to perform Contrast-Enhanced Ultrasound (CEUS).

Ultrasound Int Open. 2018; 4: E2-E15

Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on ultrasound contrast agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Ultrasound Med Biol. 2006; 32: 1369-1375

An efficacy and safety study of Sonazoid and SonoVue in participants with focal liver lesions, undergoing pre- and post-contrast ultrasound imaging. ClinicalTrials.gov identifier: NCT03335566.

(Available at:) (Accessed December 20, 2021)Lv K. Zhai H. Jiang Y. et al.

Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions.

Abdom Radiol (NY). 2021; 46: 4647-4659Kim T.K. Noh S.Y. Wilson S.R. et al.

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.

Clin Mol Hepatol. 2017; 23: 280-289American College of Radiology Committee on LI-RADS® (Liver)

CEUS LI-RADS® v2017 CORE.

(Available at:) (Accessed on December 21, 2021)

Intraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trends.

Liver Cancer. 2013; 2: 16-24Zhang K. Kokudo N. Hasegawa K. et al.

Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma.

Arch Surg. 2007; 142: 1170-1176Torzilli G. Palmisano A. Del Fabbro D. et al.

Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience.

Ann Surg Oncol. 2007; 14: 1347-1355Takigawa Y. Sugawara Y. Yamamoto J. et al.

New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma.

Ultrasound Med Biol. 2001; 27: 151-156Torzilli G. Minagawa M. Takayama T. et al.

Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy.

Hepatology. 1999; 30: 889-893

The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions.

Ultrasonography. 2015; 34: 246-257Arita J. Takahashi M. Hata S. et al.

Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.

Ann Surg. 2011; 254: 992-999Mitsunori Y. Tanaka S. Nakamura N. et al.

Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.

J Hepatobiliary Pancreat Sci. 2013; 20: 234-242Abo T. Nanashima A. Tobinaga S. et al.

Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging.

Eur J Surg Oncol. 2015; 41: 257-264Zhai H.Y. Liang P. Yu J. et al.

Comparison of sonazoid and sonovue in the diagnosis of focal liver lesions: a preliminary study.

J Ultrasound Med. 2019; 38: 2417-2425Engstrand J. Nilsson H. Strömberg C. et al.

Colorectal cancer liver metastases - a population-based study on incidence, management and survival.

BMC Cancer. 2018; 18: 78Evrard S. Poston G. Kissmeyer-Nielsen P. et al.

Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.

PLoS One. 2014; 9: e114404Imai K. Allard M.A. Benitez C.C. et al.

Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?.

Oncologist. 2016; 21: 887-894Fergadi M.P. Magouliotis D.E. Vlychou M. et al.

A meta-analysis evaluating contrast-enhanced intraoperative ultrasound (CE-IOUS) in the context of surgery for colorectal liver metastases.

Abdom Radiol (NY). 2021; 46: 4178-4188Liu W. Zhang Z.Y. Yin S.S. et al.

Contrast-enhanced intraoperative ultrasound improved sensitivity and positive predictive value in colorectal liver metastasis: a systematic review and meta-analysis.

Ann Surg Oncol. 2021; 28: 3763-3773Stavrou G.A. Stang A. Raptis D.A. et al.

Intraoperative (Contrast-Enhanced) ultrasound has the highest diagnostic accuracy of any imaging modality in resection of colorectal liver metastases.

J Gastrointest Surg. 2021; 25: 3160-3169Benoist S. Brouquet A. Penna C. et al.

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?.

J Clin Oncol. 2006; 24: 3939-3945Muaddi H. Silva S. Choi W.J. et al.

When is a ghost really gone? A systematic review and meta-analysis of the accuracy of imaging modalities to predict complete pathological response of colorectal cancer liver metastases after chemotherapy.

Ann Surg Oncol. 2021; 28: 6805-6813Shiozawa K. Watanabe M. Ikehara T. et al.

Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.

J Clin Ultrasound. 2017; 45: 138-144Hatanaka K. Kudo M. Minami Y. et al.

Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.

Oncology. 2008; 75: 42-47Hammerstingl R. Huppertz A. Breuer J. et al.

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Eur Radiol. 2008; 18: 457-467Muhi A. Ichikawa T. Motosugi U. et al.

Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.

J Magn Reson Imaging. 2011; 34: 326-335Iwamoto T. Imai Y. Kogita S. et al.

Comparison of contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI for the diagnosis of macroscopic type of hepatocellular carcinoma.

Dig Dis. 2016; 34: 679-686Oba A. Mise Y. Ito H. et al.

Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.

HPB (Oxford). 2018; 20: 708-714Arita J. Ono Y. Takahashi M. et al.

Routine preoperative liver-specific magnetic resonance imaging does not exclude the necessity of contrast-enhanced intraoperative ultrasound in hepatic resection for colorectal liver metastasis.

Ann Surg. 2015; 262: 1086-1091